Her postdoctoral research was conducted with a team of CNRS researchers in Paris, France, where she employed biochemical and gene therapy technologies to investigate the impact of protein aggregation in Parkinson's disease. (theleadershipalliance.org)
«Tau forms toxic protein aggregations in the brains of Alzheimer patients.» (gladstone.org)
With his Pioneer Award, Ismagilov will develop droplet - based microfluidic technologies for quantitative studies of protein aggregation diseases and aging at the molecular level and in entire organisms. (uchospitals.edu)